Return to content in this issue
Efficacy of Mepolizumab Extended Interval Dosing for 2 Asthmatic Patients With Chronic Eosinophilic Pneumonia
Sato H, Miyata Y, Inoue H, Tanaka A, Sagara H
Department of Internal Medicine, Division of Respiratory Medicine and Allergology, Showa University School of Medicine, Tokyo, Japan
J Investig Allergol Clin Immunol 2021; Vol 31(5)
: 459-460
doi: 10.18176/jiaci.0671
Key words: Chronic eosinophilic pneumonia, Mepolizumab, Anti-IL-5 monoclonal antibody, Asthma, Extended interval dosing
| Title | Type | Size | |
|---|---|---|---|
 |
10.18176_jiaci.0671_suppl-material_1.pdf | 273.54 Kb |
